We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05353439
Brief Title: Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

First Submitted : April 23, 2022
First Submitted that Met QC Criteria : April 23, 2022
First Posted : April 29, 2022

Last Update Submitted that Met QC Criteria : March 7, 2023
Last Update Posted : March 8, 2023